UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis

Surgical oncology, 2019-03, Vol.28, p.228-235

2019

Volltextzugriff (PDF)

A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma

European journal of cancer (1990), 2021-08, Vol.153, p.109-122

2021

Volltextzugriff (PDF)

Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation

Radiation oncology (London, England), 2012-11, Vol.7 (1), p.199-199, Article 199

2012

Volltextzugriff (PDF)

Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries

Current cancer therapy reviews, 2018-08, Vol.14 (2), p.120-136

2018

Volltextzugriff (PDF)

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma

PloS one, 2016-06, Vol.11 (6), p.e0157969-e0157969

2016

Volltextzugriff (PDF)

EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

BMC bioinformatics, 2015-03, Vol.16 (1), p.85-85, Article 85

2015

Volltextzugriff (PDF)

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG

Head & neck, 2019-10, Vol.41 (10), p.3661-3669

2019

Volltextzugriff (PDF)

Corrigendum to: “Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma” [J Hepatol (2020) 121-129]

Journal of hepatology, 2020-11, Vol.73 (5), p.1295-1296

2020

Volltextzugriff (PDF)

Correlation of outcome with early metabolic response on FDG-PET in treatment of locally advanced nasopharyngeal carcinoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17555-e17555

2017

Volltextzugriff (PDF)

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Cancer, 2015-08, Vol.121 (16), p.2720-2729

2015

Volltextzugriff (PDF)

Whole-Field Simultaneous Integrated-Boost Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2010-01, Vol.76 (1), p.138-145

2010

Volltextzugriff (PDF)

Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management - A Systematic Review

Cancer management and research, 2022-01, Vol.14, p.339-366

2022

Volltextzugriff (PDF)

Dose volume effects of re‐irradiation for locally recurrent nasopharyngeal carcinoma

Head & neck, 2020-02, Vol.42 (2), p.180-187

2020

Volltextzugriff (PDF)

Case sharing of a patient re‐challenged with afatinib for EGFR‐mutated advanced non–small cell lung cancer

Asia-Pacific journal of clinical oncology, 2018-03, Vol.14 (S1), p.4-6

Lee, Victor H.F.

2018

Volltextzugriff (PDF)

The trends in lung cancer prevalence, incidence, and survival in Hong Kong over the past two decades (2002–2021): a population-based study

The Lancet regional health. Western Pacific, 2024-04, Vol.45, p.101030, Article 101030

2024

Volltextzugriff (PDF)

Dosimetric Predictors of Radiation-induced Acute Nausea and Vomiting in IMRT for Nasopharyngeal Cancer

International journal of radiation oncology, biology, physics, 2012-09, Vol.84 (1), p.176-182

2012

Volltextzugriff (PDF)

Abstract LB-196: EGFR-mutant lung adenocarcinomas mutation profiles reveal ARID1A might be a novel tyrosine kinase resistance pathway

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-196-LB-196

2018

Volltextzugriff (PDF)

Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties

Computers in biology and medicine, 2015-08, Vol.63, p.293-300

2015

Volltextzugriff (PDF)

Factors correlating with shorter survival after treatment: Aiding oncologists to choose who (not) to receive palliative systemic therapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21654-e21654

2016

Volltextzugriff (PDF)

Abstract LB-274: Whole-exome sequencing reveals tyrosine kinase-resistant mutations in pretreatment EGFR-mutant lung adenocarcinomas

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.LB-274-LB-274

2017

Volltextzugriff (PDF)

Can Intensity-Modulated Radiotherapy Preserve Oral Health-Related Quality of Life of Nasopharyngeal Carcinoma Patients?

International journal of radiation oncology, biology, physics, 2012-06, Vol.83 (2), p.e213-e221

2012

Volltextzugriff (PDF)

Prognostic factors for oligometastasis after 1 st line first or second generation TKI for EGFR-mutated metastatic NSCLC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20521-e20521

2017

Volltextzugriff (PDF)

Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong

Hong Kong medical journal = Xianggang yi xue za zhi, 2014-06, Vol.20 (3), p.178-186

2014

Volltextzugriff (PDF)

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6002-6002

2017

Volltextzugriff (PDF)

Serial early post-IMRT undetectable plasma EBV DNA to predict outcomes in non-metastatic nasopharyngeal cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6007-6007

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(13)
Oncology
(12)
Male
(11)
Female
(10)
Middle Aged
(9)
Patients
(9)
Adult
(8)
Aged
(8)
Nasopharyngeal Carcinoma
(8)
Lung Cancer
(7)
Radiation Therapy
(7)
Survival
(7)
Radiation
(6)
Tumors
(6)
Aged, 80 And Over
(5)
Cancer Therapies
(5)
Chemotherapy
(5)
Nasopharyngeal Neoplasms - Radiotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis

A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma

Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation

Systemic Treatment of Chest Tumors: Highlighting Some Differences Between Eastern and Western Countries

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma

EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG

Corrigendum to: “Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma” [J Hepatol (2020) 121-129]

Correlation of outcome with early metabolic response on FDG-PET in treatment of locally advanced nasopharyngeal carcinoma

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Whole-Field Simultaneous Integrated-Boost Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma

Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management - A Systematic Review

Dose volume effects of re‐irradiation for locally recurrent nasopharyngeal carcinoma

Case sharing of a patient re‐challenged with afatinib for EGFR‐mutated advanced non–small cell lung cancer

The trends in lung cancer prevalence, incidence, and survival in Hong Kong over the past two decades (2002–2021): a population-based study

Dosimetric Predictors of Radiation-induced Acute Nausea and Vomiting in IMRT for Nasopharyngeal Cancer

Abstract LB-196: EGFR-mutant lung adenocarcinomas mutation profiles reveal ARID1A might be a novel tyrosine kinase resistance pathway

Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties

Factors correlating with shorter survival after treatment: Aiding oncologists to choose who (not) to receive palliative systemic therapy

Abstract LB-274: Whole-exome sequencing reveals tyrosine kinase-resistant mutations in pretreatment EGFR-mutant lung adenocarcinomas

Can Intensity-Modulated Radiotherapy Preserve Oral Health-Related Quality of Life of Nasopharyngeal Carcinoma Patients?

Prognostic factors for oligometastasis after 1 st line first or second generation TKI for EGFR-mutated metastatic NSCLC

Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Serial early post-IMRT undetectable plasma EBV DNA to predict outcomes in non-metastatic nasopharyngeal cancer

Suchergebnisse filtern